Anders Sundstrom
Overview
Explore the profile of Anders Sundstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Fors A, Forslund T, Sundstrom A, Wettermark B
Eur J Clin Pharmacol
. 2025 Mar;
PMID: 40074942
Purpose: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained considerable media attention, but there is limited knowledge about those receiving the drugs. This study aimed to assess demographic characteristics and...
3.
Lunghi C, Valetto M, Caracciolo A, Bramke I, Caroli S, Bottoni P, et al.
Drug Saf
. 2024 Dec;
48(4):315-320.
PMID: 39656351
No abstract available.
4.
Zethelius B, Attelind S, Westman G, Ljung R, Sundstrom A
Vaccine X
. 2024 Oct;
21:100571.
PMID: 39474208
Background: During the COVID-19 vaccination campaign in Sweden, pulmonary embolism (PE) was a frequently reported suspected serious adverse drug reaction. The aim was to estimate risk of PE following vaccination...
5.
Hviid A, Nieminen T, Pihlstrom N, Gunnes N, Dahl J, Karlstad O, et al.
Eur Heart J
. 2024 Feb;
45(15):1327-1335.
PMID: 38365960
Background And Aims: The SARS-CoV-2 mRNA vaccines are associated with an increased risk of myocarditis. This association appears to be strongest in male adolescents and younger males and after the...
6.
Kalkner K, Sundstrom A, Haverinen M, Nordback K, Arthurson V, Zethelius B, et al.
Ups J Med Sci
. 2024 Jan;
128.
PMID: 38188250
Background: Chloroquine and hydroxychloroquine (C/HC) received considerable international media attention due to anticipated treatment effect in COVID-19. This led to increased prescriptions threatening to generate product shortages for patients prescribed...
7.
Zethelius B, Sundstrom A, Nordback K, Kalkner K, Ljung R
Int J Clin Pharmacol Ther
. 2024 Jan;
62(3):109-114.
PMID: 38174883
Objective: To report on hoarding of prescribed medicines, with focus on insulins, in the early phase of the COVID-19 pandemic and on regulatory actions taken to avoid shortage. Materials And...
8.
Bergman E, Durlich L, Arthurson V, Sundstrom A, Larsson M, Bhuiyan S, et al.
PLOS Digit Health
. 2023 Dec;
2(12):e0000409.
PMID: 38055685
Post-marketing reports of suspected adverse drug reactions are important for establishing the safety profile of a medicinal product. However, a high influx of reports poses a challenge for regulatory authorities...
9.
Ekenberg M, Qvarnstrom M, Sundstrom A, Martinell M, Wettermark B
Eur J Clin Pharmacol
. 2023 Oct;
80(1):53-63.
PMID: 37870618
Purpose: This study aims to determine initiation and persistence for patients with type 2 diabetes receiving their first prescription of an antidiabetic agent and the associations with socioeconomic factors. Methods:...
10.
Attelind S, Eriksson N, Sundstrom A, Wadelius M, Hallberg P
Pharmacoepidemiol Drug Saf
. 2023 Aug;
32(12):1431-1438.
PMID: 37580910
Introduction: In addition to identifying new safety signals, pharmacovigilance databases could be used to identify potential risk factors for adverse drug reactions (ADRs). Objective: To evaluate whether data mining in...